RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang(Sichuan University), George Miller(University of North Carolina at Chapel Hill), Brian Diskin(New York University), Jacqueline I. Kim(Miami Transplant Institute), Emma Kurz(New York University), Varshini Vasudevaraja(NYU Langone Health), Christina Almonte(Dana-Farber Cancer Institute), Berk Aykut(Duke University), Kwok‐Kin Wong(NYU Langone Health), Pardeep S. Taunk, Julie E. Mosley, Dennis O. Adeegbe(Moffitt Cancer Center), Joshua Leinwand(Icahn School of Medicine at Mount Sinai), Philip A. Harris(Centre Hospitalier de l’Université de Montréal), Michael W. Glacken(New York University), Nan Wu(Chongqing University), Jill M. Marinis(University of Pennsylvania), Deirdre Jill Cohen(Icahn School of Medicine at Mount Sinai), John D. Lich(South College), Ankita Mishra(Center for Advancing Health), Allison M. Beal(South College), Wenyu Su(Shanghai Jiao Tong University), Mautin Hundeyin(New York University), Michael Reilly, Ece Bagdatlioglu(New York University), Johana Gutierrez(New York University), Mukesh K. Mahajan, Juan Andres Kochen Rossi(New York University), Narendra Verma(University of Padua), Inedouye Yaboh(New York University), Fei Li(Xuzhou Medical College), Ting Chen(Nanchang University), Yue Wu(Shanghai Ninth People's Hospital), Jingjing Wu(Zunyi Medical University), Atsuo Ochi(LIP - Laboratory of Instrumentation and Experimental Particle Physics), James H. Thorpe(South College), Mohammed Khan, Aarif Ahsan(New York University), Shivraj Savadkar(New York University), Pamela Nassau(South College), John Bertin(Millennium Engineering and Integration (United States))
Cited by 27
Related Papers
The JAK/STAT signaling pathway: from bench to clinic
|Signal Transduction and Targeted Therapy|2021|2.4k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k